Published in Am Rev Respir Dis on January 01, 1988
Hypersensitivity pneumonitis. West J Med (1993) 1.01
Immuno-inflammatory cell dynamics during cutaneous wound healing. J Anat (1999) 0.94
Immune responses in the lung: basic principles. Lung (1990) 0.75
Bronchoalveolar lavage and the immunology of lung cancer. Lung (1990) 0.75
Characteristics and clinical significance of the lymphocytic alveolitis in interstitial lung disorders. Lung (1990) 0.75
Diabetes impairs progenitor cell mobilisation after hindlimb ischaemia-reperfusion injury in rats. Diabetologia (2006) 2.03
Endothelial progenitors in pulmonary hypertension: new pathophysiology and therapeutic implications. Eur Respir J (2010) 1.83
The lymphoproliferative disease of granular lymphocytes: updated criteria for diagnosis. Blood (1997) 1.75
Cxcr3 and its ligand CXCL10 are expressed by inflammatory cells infiltrating lung allografts and mediate chemotaxis of T cells at sites of rejection. Am J Pathol (2001) 1.63
Knowledge and attitudes of Italian medical staff towards the approach and treatment of patients in pain. J Pain Symptom Manage (2001) 1.60
Involvement of the IP-10 chemokine in sarcoid granulomatous reactions. J Immunol (1998) 1.56
Identification of NKp80, a novel triggering molecule expressed by human NK cells. Eur J Immunol (2001) 1.46
Shelhigh No-React porcine pulmonic valve conduit: a new alternative to the homograft. Ann Thorac Surg (2001) 1.42
Polyvinyl chloride pneumoconiosis: epidemiological study of exposed workers. J Occup Med (1979) 1.32
Activated T cells with immunoregulatory functions at different sites of involvement in sarcoidosis. Phenotypic and functional evaluations. Ann N Y Acad Sci (1986) 1.30
CXC chemokines IP-10 and mig expression and direct migration of pulmonary CD8+/CXCR3+ T cells in the lungs of patients with HIV infection and T-cell alveolitis. Am J Respir Crit Care Med (2000) 1.27
State of the art in natural killer cell malignancies. Int J Lab Hematol (2011) 1.26
Revision of previous Fontan connections to total extracardiac cavopulmonary anastomosis: A multicenter experience. J Thorac Cardiovasc Surg (2000) 1.25
Immunohistochemical analysis of sarcoid granulomas. Evaluation of Ki67+ and interleukin-1+ cells. Am J Pathol (1988) 1.23
Role of IL-15, IL-2, and their receptors in the development of T cell alveolitis in pulmonary sarcoidosis. J Immunol (1996) 1.21
Glucose tolerance is negatively associated with circulating progenitor cell levels. Diabetologia (2007) 1.21
Bronchoalveolar lavage and lung histology. Comparative analysis of inflammatory and immunocompetent cells in patients with sarcoidosis and hypersensitivity pneumonitis. Am Rev Respir Dis (1985) 1.18
Antibodies to the IL-12 receptor beta 2 chain mark human Th1 but not Th2 cells in vitro and in vivo. J Immunol (1999) 1.15
The lymphoproliferative disease of granular lymphocytes. A heterogeneous disorder ranging from indolent to aggressive conditions. Cancer (1987) 1.15
Interleukin-15 triggers the proliferation and cytotoxicity of granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes. Blood (1997) 1.14
Increased serum levels of soluble interleukin-2 receptor in patients with systemic lupus erythematosus and rheumatoid arthritis. J Clin Immunol (1988) 1.10
Pleural effusion in sarcoidosis: a case report. Sarcoidosis (1994) 1.09
The chemokine receptor CXCR3 is expressed on malignant B cells and mediates chemotaxis. J Clin Invest (1999) 1.09
Soluble interleukin-2 receptors in the serum of patients with Hodgkin's disease. Br J Cancer (1987) 1.09
Effect of natural grass pollen exposure on exhaled nitric oxide in asthmatic children. Am J Respir Crit Care Med (1999) 1.08
"The sarcoidosis map": a joint survey of clinical and immunogenetic findings in two European countries. Am J Respir Crit Care Med (1995) 1.08
Side-effect profile of fluoxetine in comparison with other SSRIs, tricyclic and newer antidepressants: a meta-analysis of clinical trial data. Pharmacopsychiatry (2005) 1.07
CD8+ T lymphocytes in the lung of acquired immunodeficiency syndrome patients harbor human immunodeficiency virus type 1. Blood (1995) 1.05
Prevalence and risk factors of chronic respiratory disease in a farming population. Med Lav (1984) 1.05
Expression of tumor necrosis factor-receptor superfamily members by lung T lymphocytes in interstitial lung disease. Am J Respir Crit Care Med (1996) 1.03
Evidence of cells bearing interleukin-2 receptor at sites of disease activity in sarcoid patients. Clin Exp Immunol (1984) 1.03
HIV-1 and the lung. Infectivity, pathogenic mechanisms, and cellular immune responses taking place in the lower respiratory tract. Am Rev Respir Dis (1993) 1.02
Extracorporeal photochemotherapy may improve outcome in children with acute GVHD. Bone Marrow Transplant (2008) 1.01
Immunosuppressive therapy prevents recurrent pericarditis. J Am Coll Cardiol (1995) 1.01
Clinical evaluation of seven tumour markers in lung cancer diagnosis: can any combination improve the results? Br J Cancer (1995) 1.01
Clonal studies of CD3- lymphoproliferative disease of granular lymphocytes. Blood (1993) 1.00
Expression of HLA-A2 antigen in human melanoma cell lines and its role in T-cell recognition. Cancer Res (1991) 0.99
Phenotypical and functional analysis of bronchoalveolar lavage lymphocytes in patients with HIV infection. Am Rev Respir Dis (1988) 0.99
An unbalanced monocyte polarisation in peripheral blood and bone marrow of patients with type 2 diabetes has an impact on microangiopathy. Diabetologia (2013) 0.99
T-lymphocyte subpopulations in chronic lymphocytic leukemia: a quantitative and functional study. Cancer (1981) 0.99
Pulmonary alveolar macrophages in patients with sarcoidosis and hypersensitivity pneumonitis: characterization by monoclonal antibodies. J Clin Immunol (1987) 0.97
Interleukin-15 promotes the growth of leukemic cells of patients with B-cell chronic lymphoproliferative disorders. Blood (1996) 0.97
Immunophenotypic characterization of the cell infiltrate in five cases of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). Hum Pathol (1992) 0.97
Oxaliplatin: available data in non-colorectal gastrointestinal malignancies. Crit Rev Oncol Hematol (2001) 0.97
High serum levels of soluble interleukin 2 receptor in patients with B chronic lymphocytic leukemia. Blood (1987) 0.97
Immunohistological study in sarcoidosis: evaluation at different sites of disease activity. Clin Immunol Immunopathol (1984) 0.96
Rituximab-responsive CIDP. Eur J Neurol (2004) 0.96
7.5% hypertonic saline versus 20% mannitol during elective neurosurgical supratentorial procedures. J Neurosurg Anesthesiol (1997) 0.95
The nutritional and safety assessment of breast milk substitutes and other dietary products for infants: a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr (2001) 0.95
Regulation of alveolar macrophage-T cell interactions during Th1-type sarcoid inflammatory process. Am J Physiol (1999) 0.95
Lyn-mediated SHP-1 recruitment to CD5 contributes to resistance to apoptosis of B-cell chronic lymphocytic leukemia cells. Leukemia (2011) 0.94
B lymphocytes from patients with chronic lymphoproliferative disorders are equipped with different costimulatory molecules. Cancer Res (1997) 0.94
Tumour-infiltrating lymphocytes bear the 75 kDa tumour necrosis factor receptor. Br J Cancer (1995) 0.94
Defective recruitment, survival and proliferation of bone marrow-derived progenitor cells at sites of delayed diabetic wound healing in mice. Diabetologia (2010) 0.94
Acceptability, sensitivity and content validity of the VECS and VSSS in measuring expectations and satisfaction in psychiatric patients and their relatives. Soc Psychiatry Psychiatr Epidemiol (1994) 0.93
Immunoregulation in sarcoidosis. Clin Immunol Immunopathol (1981) 0.93
Clinicopathological features of aggressive large granular lymphocyte leukaemia resemble Fas ligand transgenic mice. Br J Haematol (2000) 0.93
Genotypic evaluation of killer immunoglobulin-like receptors in NK-type lymphoproliferative disease of granular lymphocytes. Leukemia (2007) 0.93